Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Pharmaceutical Isolator Market to reach USD 4.13 Billion by 2035 at 10.8% CAGR
EIN Presswire
Pharmaceutical Isolator Market to Surge from USD 1.66 Billion in 2026 to USD 4.13 Billion by 2035-Powered by Regulatory Tightening, Biologics Pipeline Expansion NY, CA, UNITED STATES, July 13, 2026 /EINPresswire.com/ -- As per Market Research...
Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience
GlobeNewswire, Inc.
TORONTO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage company developing potentially life-improving medicines to treat degenerative muscle diseases, today announced the formation of a...
Global Anaphylaxis Market Expected to Surpass $5.14 Billion by 2030
EIN Presswire
The Business Research Company’s Anaphylaxis Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, October 30, 2026 /EINPresswire.com/ -- The global anaphylaxis market is gaining...
Ketogenic Foundation Announces 2026 Conference Exploring the Future of Metabolic Health and Chronic Disease Care
GlobeNewswire, Inc.
DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The Ketogenic Foundation today announced Frontiers in Metabolic Health & Nutritional Ketosis: Advancing Science and Practice, taking place October 4–7, 2026, at The Sheraton Dallas Hotel.
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
GlobeNewswire, Inc.
Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development experience including roles at Sumitomo Pharma, Takeda, and Novartis Appointment further strengthens Entera’s clinical execution team and late-stage...
China’s Permanent Representative to the United Nations Office at Geneva and Other International Organizations in Switzerland Ambassador Jia Guide Exchanges Views with Permanent Representatives of Several Countries
Ministry of Foreign Affairs of the People's Republic of China
On August 13, 2026, Ambassador Jia Guide, Permanent Representative of China to the United Nations Office at Geneva and other international organizations in Switzerland, held a collective meeting with Permanent Representatives of Cambodia, Nepal,...
HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®
GlobeNewswire, Inc.
— First global Phase III trial to show significant progression-free and overall survival benefits in this setting — — SAFFRON trial results reinforce TAGRISSO® as the backbone therapy across EGFRm lung cancer — HONG KONG and SHANGHAI and FLORHAM...
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
GlobeNewswire, Inc.
BEDFORD, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver...
AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)
GlobeNewswire, Inc.
AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD) Ongoing Phase 2 VacSYn study to expand to sites in USA with Investigational New Drug (IND) clearance...
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
GlobeNewswire, Inc.
Boehringer Ingelheim announced today that it has acquired Evax AG, a Swiss biotech company focused on equine health.
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
Phase 3 IZAR-1 trial in bio-naïve patients met all clinical endpoints at Week 16 for 60 mg sonelokimab The primary endpoint of ACR50 was met with a high response of 42.1% for sonelokimab’s 60 mg with induction, and significant responses were...
Top 10 Private Label Skincare Manufacturers in 2026: Advancing Custom Beauty Solutions
EIN Presswire
A 2026 guide to ten private label skincare manufacturers.
Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1
GlobeNewswire, Inc.
Prescription Drug User Fee Act target action date is February 12, 2027 If approved, tinlarebant would be the first-ever approved treatment for Stargardt Disease Type 1 SAN DIEGO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE)...
Er-Kim Announces LOQTORZI® (toripalimab) Included on Poland’s Ministry of Health Reimbursement List
EIN Presswire
WARSAW, NY, POLAND, August 11, 2026 /EINPresswire.com/ -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, is pleased to announce the inclusion of LOQTORZI®...
Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology
GlobeNewswire, Inc.
People with AAE-C1INH experience frequent misdiagnoses, emergency medical events, and wide-ranging impact on physical, emotional, and social well-being Study results informed the design and endpoint selection of the ongoing Phase 3 CREAATE study...
The MEDICE Health Family advances unified approach to regulated content operations across European affiliates
EIN Presswire
Specialty pharmaceutical group expands use of Vodori to standardize content governance and connect approved materials with Salesforce’s Agentforce Life Sciences CHICAGO, IL, UNITED STATES, August 6, 2026 /EINPresswire.com/ -- The MEDICE Health...
Spirited Paw® Healthy Mind By Standard Process® Named 2026 Senior Dog Nutrition Product of the Year
GlobeNewswire, Inc.
PALMYRA, Wis., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Standard Process®, a leader in whole food-based nutritional supplements, announced today that Healthy Mind from Spirited Paw®, its direct-to-consumer pet wellness brand, has been named the 2026...
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
GlobeNewswire, Inc.
Tokyo, Japan and Cambridge, UK, 7 August 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter ended 30 June 2026. The full report can be...
Disposable Hospital Supplies Market Report Evaluates Growth Drivers, Challenges And Market Dynamics
EIN Presswire
The Business Research Company’s Disposable Hospital Supplies Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, August 5, 2026 /EINPresswire.com/ -- The disposable hospital supplies...
Topical RNA Delivery Opens a New Era for Dermatology, Healthy Aging & Regenerative Beauty
GlobeNewswire, Inc.
Paris - FRANCE, Aug. 06, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE August 6, 2026 Topical RNA Delivery Opens a New Era for Dermatology, Healthy Aging & Regenerative Beauty GEG Tech today announces a major scientific milestone with the publication of...
Sign up for:
Switzerland Health Monitor
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.